ANVISA registration 10387650141Active

C-REACTIVE PROTEIN

Name: C-REACTIVE PROTEIN — ANVISA registration 10387650141
Creator: DXGEN CORP.
Keywords: C-REACTIVE PROTEIN, PROTEÍNA C REATIVA, Kit para teste Proteína C Reativa Epithod®, 10387650141, Risk Class II, ANVISA registration

ANVISA Registration Number: 10387650141CAPRICORN TECHNOLOGIES DO BRASIL LTDADXGEN CORP.Risk Class II

Verified

Device names

Technical name: C-REACTIVE PROTEIN
Commercial name: Kit para teste Proteína C Reativa Epithod®
Risk class: Class II

Registration details

Registration Number: 10387650141
Process Number: 25351195053202345
CNPJ: 02823683000102

Company information

Registration Holder: CAPRICORN TECHNOLOGIES DO BRASIL LTDA
Manufacturer: DXGEN CORP.
Manufacturing Country: South Korea

Dates and status

Publication Date: May 02, 2023
Validity: VIGENTE
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for C-REACTIVE PROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10387650141 and manufactured by DXGEN CORP.. The registration is held by CAPRICORN TECHNOLOGIES DO BRASIL LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.